<?xml version='1.0' encoding='UTF-8'?>
<lsdb id='submission0001' xmlns='http://gen2phen.org/lsdb/2.0'
  xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' 
  xsi:schemaLocation='http://gen2phen.org/lsdb/1.1 
  file:/Users/muilu/Documents/Dev/SVN_repos/gen2phen/trunk/data_formats/xml/lsdb.xsd'>
 <source id='ZAP70base' version='1.4' uri='http://bioinf.uta.fi/ZAP70base/'>
	<name>ZAP70base</name>
	<url>http://bioinf.uta.fi/ZAP70base/</url>
	<contact>
		<name>Mauno Vihinen</name>
		<address>Institute of Medical Technology ,FI-33014 University of Tampere, Finland</address>
	</contact>
	<acknowledgement><name>Tampere University Hospital Medical Research Fund</name></acknowledgement>
	<acknowledgement><name>European Union</name></acknowledgement>
 </source>
 <individual id='Z0006'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.11708C&gt;A</name>
		<exon>e3</exon>
		<consequence term='A point mutation in the exon 3 leading to an amino acid change in the SH2_1 domain '/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.239c&gt;a</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Pro80Gln</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25518A&gt;T</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 13 leading to an amino acid change in the SH2_1 domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1714a&gt;u</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Met572Leu</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0012'>
	<gender code='1'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
		<comment term='symptom'><text>Infections: P. Carinii pneumonia</text></comment>
	</phenotype>
	<population term='Caucasoid' type='region' />
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.14540C&gt;T</name>
		<exon>e1</exon>
		<consequence term='point mutation in the exon 9 leading to an  amino acid change in the TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0004'>
	<gender code='2'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
		<comment term='symptom'><text>Failure to thrive</text></comment>
	</phenotype>
	<population term='Caucasoid' type='ethnic' />
	<population term='USA' type='region' />
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25217_25229delAAGTGGTACGCAC</name>
		<exon>e1</exon>
		<consequence term='A frame shift deletion mutation in the exon 12 leading to a premature stop codon in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1510_1522delaagugguacgcac</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Lys504fsX35</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0011'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
		<comment term='symptom'><text>Infections: P. Carinii pneumonia</text></comment>
		<comment term='symptom'><text>Severe or disseminated varicella</text></comment>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25217_25229delAAGTGGTACGCAC</name>
		<exon>e1</exon>
		<consequence term='A frame shift deletion mutation in the exon 12 leading to a premature stop codon in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1510_1522delaagugguacgcac</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Lys504fsX35</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0007'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25227C&gt;T</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1520c&gt;u</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ala507Val</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0008'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25227C&gt;T</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1520c&gt;u</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ala507Val</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0013'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25227C&gt;T</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1520c&gt;u</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ala507Val</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0014'>
	<gender code='9'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25227C&gt;T</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain'/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1520c&gt;u</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ala507Val</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0005'>
	<gender code='1'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25261C&gt;A</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain '/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1554c&gt;a</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ser518Arg</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic donor  splice site in the intron 12 leading to inframe insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0009'>
	<gender code='1'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25261C&gt;A</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain '/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1554c&gt;a</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ser518Arg</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic donor  splice site in the intron 12 leading to inframe insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0010'>
	<gender code='2'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.25261C&gt;A</name>
		<exon>e1</exon>
		<consequence term='A point mutation in the exon 12 leading to an amino acid change in the TK domain '/>
		<seq_changes>
			<variant type='RNA'>
				<ref_seq source='IDRefSeq' accession='C0057' />
				<name scheme='HGVS'>r.1554c&gt;a</name>
				<seq_changes>
					<variant type='AA'>
						<ref_seq source='UniProt' accession='P43403' />
						<name scheme='HGVS'>p.Ser518Arg</name>
					</variant>
				</seq_changes>
			</variant>
		</seq_changes>
	</variant>
	<variant diploid_count='1'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic splice  acceptor site in the intron 12 leading to inframe  insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0001'>
	<gender code='2'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic  splice acceptor site in the intron 12 leading to inframe insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0002'>
	<gender code='2'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic  splice acceptor site in the intron 12 leading to inframe insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
 <individual id='Z0003'>
	<gender code='2'/>
	<phenotype term='T-B- severe combined immunodeficiency'>
	</phenotype>
	<variant diploid_count='2'>
		<gene source='HGNC' accession='ZAP70'/>
		<ref_seq source='IDRefSeq' accession='D0057' />
		<name scheme='HGVS'>g.IVS12-11G&gt;A</name>
		<exon>i1</exon>
		<consequence term='point mutation creates a new cryptic  splice acceptor site in the intron 12 leading to inframe insertion of three amino acids in TK domain'/>
	</variant>
	<db_xref  source='OMIM' accession='176947' />
 </individual>
</lsdb>
